Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors

Advances in Therapy
Hiu-yan ChanRonald M Bukowski

Abstract

Renal cell carcinoma (RCC) and neuroendocrine tumors (NET) are uncommon malignancies, highly resistant to chemotherapy, that have emerged as attractive platforms for evaluating novel targeted regimens. Everolimus is an oral rapamycin derivative within the mammalian target of rapamycin class of agents. Preclinical series have shown that everolimus exhibits anticancer effects in RCC and NET cell lines. A phase 3 placebo-controlled study in advanced clear-cell RCC, known as RECORD-1 (for "REnal Cell cancer treatment with Oral RAD001 given Daily"), documented that everolimus stabilizes tumor progression, prolongs progression-free survival and has acceptable tolerability in patients previously treated with the multikinase inhibitors sunitinib and/or sorafenib. Everolimus has been granted regulatory approval for use in sunitinib-pretreated and/or sorafenib-pretreated advanced RCC and incorporated into clinical practice guidelines, and the RECORD-1 safety data are being used to develop recommendations for managing clinically important adverse events in everolimus-treated patients. Ongoing clinical trials are evaluating everolimus as earlier RCC therapy (first-line for advanced disease and as neoadjuvant therapy), in non-clear-cell tum...Continue Reading

References

Mar 1, 1981·Cancer Treatment Reviews·J Douros, M Suffness
Feb 25, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S VignotE Raymond
Dec 13, 2006·The Journal of Urology·Victoria A RobbElizabeth P Henske
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Premal H PatelRobert J Motzer
Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
Jan 12, 2007·The New England Journal of Medicine·James Brugarolas
Mar 27, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·James C Yao
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Jun 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YaoDouglas B Evans
Sep 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YaoFunda Meric-Bernstam
Nov 4, 2008·Endocrine-related Cancer·Dorota Dworakowska, Ashley B Grossman
Dec 4, 2008·Cancer·Arkadiusz Z DudekCezary Szczylik
Jan 9, 2009·The New England Journal of Medicine·Matthew H KulkeJames C Yao
Jan 23, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Theo M de ReijkeMatti Aapro
Mar 3, 2009·Critical Reviews in Oncology/hematology·Gabriele CapursoGianfranco Delle Fave
Apr 2, 2009·Current Oncology Reports·Jennifer A Chan, Matthew H Kulke
May 9, 2009·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M R DruceA B Grossman
May 19, 2009·The Journal of Urology·M P SablinB Escudier
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EscudierUNKNOWN ESMO Guidelines Working Group
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerRobert A Figlin
Jul 25, 2009·Nature Reviews. Drug Discovery·Pasi A JänneJeff Settleman
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe Di LorenzoSabino De Placido
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edoardo MissiagliaAldo Scarpa
Nov 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YaoBertram Wiedenmann
Dec 17, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E HutsonRobert A Figlin
Jul 17, 2010·European Urology·Börje LjungbergUNKNOWN European Association of Urology Guideline Group
Apr 13, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Camillo PortaRobert J Motzer

❮ Previous
Next ❯

Citations

Jan 25, 2013·Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology·Yoshimitsu KomemushiYukio Homma
Sep 7, 2011·Gastroenterology Clinics of North America·Robert WongRobert Gish
Nov 1, 2011·Clinical Genetics·A M LarsonE A Thiele
Jan 30, 2015·British Journal of Pharmacology·Doriano FabbroHenrik Moebitz
Jun 25, 2016·International Journal of Molecular Sciences·Moto Kajiwara, Satohiro Masuda
Sep 6, 2012·The Annals of Pharmacotherapy·Lisa A ThompsonCindy L O'Bryant
May 23, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Hideyuki Abe, Takao Kamai
Feb 18, 2015·Current Opinion in Pediatrics·John J Bissler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.